Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction

Circulation Journal : Official Journal of the Japanese Circulation Society
Eiichiro OkaWataru Shimizu

Abstract

Landiolol, an ultra-short acting β1-selective blocker, is more effective for controlling the heart rate (HR) than digoxin in patients with atrial tachyarrhythmias and left ventricular (LV) dysfunction. The impact of the type of atrial tachyarrhythmias on the effectiveness of landiolol is uncertain. We evaluated the efficacy and safety of landiolol on tachycardiac atrial fibrillation (AF) and tachycardiac atrial flutter/atrial tachycardia (AFl/AT) in patients with reduced LV function. Methods and Results: Seventy-seven patients treated with landiolol were retrospectively analyzed. There were no significant differences in the baseline characteristics between the AF group (n=65) and AFl/AT group (n=12). Despite a higher dosage, the %change in HR from baseline to 12 and 24 h was only -10.2±12.7% and -16.1±19.4% in the AFl/AT group, while it was -28.3±13.2% and -31.3±11.3% in the AF group (P<0.02), respectively. The prevalence of the responders to landiolol treatment was much greater in the AF group than in the AFl/AT group (P<0.001). Alternative treatments such as i.v. amiodarone and electrical cardioversion were required in 83% of the AFl/AT patients. Landiolol was ineffective in the majority of AFl/AT patients. An alternative man...Continue Reading

References

Oct 1, 1993·Journal of the American College of Cardiology·U ElkayamE Ostrzega
Sep 1, 1996·Journal of Cardiovascular Electrophysiology·F L MeijlerD Vaidya
May 7, 1998·Cardiology·U Elkayam
Jan 22, 2003·Journal of the American College of Cardiology·Philippe ChevalierPaul Touboul
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Mark A Wood
Sep 28, 2007·Pacing and Clinical Electrophysiology : PACE·Norishige MoritaTeruo Takano
Feb 26, 2008·Journal of the American College of Cardiology·Albert L Waldo, Gregory K Feld
Sep 23, 2008·Journal of Cardiovascular Electrophysiology·Clemens SteinwenderRobert Hofmann
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·Francisco J PérezMark A Wood
Jul 22, 2010·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Melissa H KongSana M Al-Khatib
Nov 5, 2013·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Linda NortonPaul Wang
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Dec 7, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Richard J SilverwoodUNKNOWN ISAAC Phase Three Study Group

❮ Previous
Next ❯

Citations

Jul 4, 2020·European Heart Journal. Case Reports·Daisuke YakabeToshihiro Nakamura
Jun 14, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Eiichiro OkaWataru Shimizu
Jun 14, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Daisuke Nitta, Teruhiko Imamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.